Head and Neck Cancer Trial, Recruiting (NCT05192655)

Head and Neck Cancer Trial, Recruiting NCT05192655 Sponsor: Charite University, Berlin, Germany Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05192655 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are over 18 years old and have been diagnosed with a type of head and neck cancer (called HNSCC), and you are being treated at the Charité hospital's Radiation Oncology or Oral and Maxillofacial Surgery department
Your treatment plan is aimed at curing the cancer (such as radiation therapy, chemotherapy combined with radiation, or surgery, or a combination of these)
Before starting treatment, you have had a special type of body scan called an FDG-PET scan, which uses a small amount of radioactive sugar to help doctors see the cancer more clearly

Who may not be able to join:

Your head and neck cancer cannot be treated with the aim of a cure
You are receiving treatment aimed at a cure but were not able to have the FDG-PET scan before your treatment began
You have previously agreed to take part in this study but have since withdrawn your consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0030-450-657057

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05192655

Sponsor: Charite University, Berlin, Germany

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: 0030-450-657057

More information: https://clinicaltrials.gov/study/NCT05192655

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are over 18 years old and have been diagnosed with a type of head and neck cancer (called HNSCC), and you are being treated at the Charité hospital's Radiation Oncology or Oral and Maxillofacial Surgery department
Your treatment plan is aimed at curing the cancer (such as radiation therapy, chemotherapy combined with radiation, or surgery, or a combination of these)
Before starting treatment, you have had a special type of body scan called an FDG-PET scan, which uses a small amount of radioactive sugar to help doctors see the cancer more clearly

Who may not be able to join:

Your head and neck cancer cannot be treated with the aim of a cure
You are receiving treatment aimed at a cure but were not able to have the FDG-PET scan before your treatment began
You have previously agreed to take part in this study but have since withdrawn your consent

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Charite University, Berlin, Germany

Registry

ClinicalTrials.gov

Start date

1 December 2021

Est. completion

1 December 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Locoregional Control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov